Form 4 for CRSP CRISPR Therapeutics AG
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-14 · accession 0000950170-25-041471 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-18 | 2025-03-17 | CRSP | Prasad Raju | CFO | S - Sale+OE | $41.80 | -3,762 | 12.7K | -23% | -$157.3K |
| D | 2025-03-18 | 2025-03-14 | CRSP | Prasad Raju | CFO | M - OptEx | — | +10.0K | 16.5K | +154% | — |
| DM | 2025-03-18 | 2025-03-14 | CRSP | Prasad Raju | CFO | A - Grant | $0.00 | +64.2K | 36.7K | New | $0 |
| D | 2025-03-18 | 2025-03-14 | CRSP | Prasad Raju | CFO | M - OptEx | — | -10.0K | 20.0K | -33% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-03-17 | S | D | 3,762 | $41.80 | 12,714 | D | — | — | (F2) Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. |
| 2 | Common | Common Shares | 2025-03-14 | M | A | 10,000 | — | 16,476 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. |
| 3 | Derivative | Restricted Stock Units | 2025-03-14 | A | A | 27,500 | $0.00 | 27,500 | D | — · — to — | 27,500 Common Shares | (F1) Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. (F5) This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029. |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-03-14 | A | A | 36,666 | $0.00 | 36,666 | D | $42.12 · — to 2035-03-14 | 36,666 Common Shares | (F4) This option was granted on March 14, 2025 with respect to 36,666 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 14, 2025. |
| 5 | Derivative | Restricted Stock Units | 2025-03-14 | M | D | 10,000 | — | 20,000 | D | — · — to — | 10,000 Common Shares | (F1) Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. (F3) This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027. |